|
C7ORF42 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62736490949555E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.45059980588758E-10 |
| Normal-vs-Stage2 |
1.339820E-02 |
| Normal-vs-Stage3 |
4.614400E-02 |
| Normal-vs-Stage4 |
1.836360E-01 |
| Stage1-vs-Stage2 |
6.910000E-01 |
| Stage1-vs-Stage3 |
1.583380E-01 |
| Stage1-vs-Stage4 |
2.358600E-01 |
| Stage2-vs-Stage3 |
4.617800E-01 |
| Stage2-vs-Stage4 |
3.841600E-01 |
| Stage3-vs-Stage4 |
7.863600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.13558076672871E-13 |
| Normal-vs-AfricanAmerican |
3.19490000000311E-06 |
| Normal-vs-Asian |
5.438000E-01 |
| Caucasian-vs-AfricanAmerican |
7.147200E-01 |
| Caucasian-vs-Asian |
4.410600E-01 |
| AfricanAmerican-vs-Asian |
4.961400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.04991620636974E-14 |
| Normal-vs-Female |
7.54839999950185E-07 |
| Male-vs-Female |
5.883600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.156200E-03 |
| Normal-vs-Extreme_Weight |
3.01299999949656E-07 |
| Normal-vs-Obese |
1.19659999686661E-08 |
| Normal-vs-Extreme_Obese |
2.506000E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.320000E-01 |
| Normal_Weight-vs-Obese |
1.535840E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.890600E-01 |
| Extreme_Weight-vs-Obese |
9.563200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.432600E-01 |
| Obese-vs-Extreme_Obese |
3.213400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.298800E-03 |
| Normal-vs-Age(41-60Yrs) |
2.18591811318447E-12 |
| Normal-vs-Age(61-80Yrs) |
7.90330000333128E-08 |
| Normal-vs-Age(81-100Yrs) |
1.570760E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.717000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.788200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.065400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.576700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.880200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.743800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62458935193399E-12 |
| Normal-VS-Type2 PRCC |
3.819800E-01 |
| Normal-VS-KIRP CIMP |
2.775400E-01 |
| Normal-VS-Unclassified PRCC |
5.824000E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.87316828714756E-12 |
| Type1 PRCC-VS-KIRP CIMP |
3.986300E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
7.464200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.647600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.935700E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.952500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.841600E-03 |
| Normal-vs-N1 |
3.870100E-02 |
| Normal-vs-N2 |
4.70159999998998E-06 |
| N0-vs-N1 |
8.323600E-01 |
| N0-vs-N2 |
2.111200E-01 |
| N1-vs-N2 |
2.639800E-01 |
|
|
